Financials
- Market Capitalization 949.4 M
- Employee 489
- Founded 2007
- CEO Mike Raab
- Website www.ardelyx.com
- Headquarter Delaware, United States
- FIGI BBG001WH4DQ3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-22.42
ratio cours/chiffre d'affaires
3.45
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2472 | GERN Geron Corporation - Common Stock | 1.51 USD | -1.31% | -1.31% | +4.86% | +4.86% | 970.13 M USD | ||
| 2485 | ANNX Annexon, Inc. - common stock | 4.96 USD | -5.52% | -2.17% | -0.20% | +133.96% | 940.31 M USD | ||
| 2487 | DSGN Design Therapeutics, Inc. - Common Stock | 15.17 USD | -0.52% | -0.72% | +27.05% | +168.50% | 949.36 M USD | ||
| 2509 | OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.36 USD | -3.99% | -4.25% | -9.91% | +26.50% | 906.48 M USD |